Jean Bennett Selected Research

Choroideremia

10/2022	Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy Trial.
1/2022	Short-term Assessment of Subfoveal Injection of Adeno-Associated Virus-Mediated hCHM Gene Augmentation in Choroideremia Using Adaptive Optics Ophthalmoscopy.
10/2019	Visual Function at the Atrophic Border in Choroideremia Assessed with Adaptive Optics Microperimetry.
1/2019	Detailed retinal phenotype of Boucher-Neuhäuser syndrome associated with mutations in PNPLA6 mimicking choroideremia.
1/2018	Comparing Clinical Perimetry and Population Receptive Field Measures in Patients with Choroideremia.
1/2017	Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.
9/2014	High-resolution adaptive optics retinal imaging of cellular structure in choroideremia.
5/2014	Adeno-associated virus 8-mediated gene therapy for choroideremia: preclinical studies in in vitro and in vivo models.
4/2003	Gene therapy for choroideremia: in vitro rescue mediated by recombinant adenovirus.
3/2002	Macular pigment and lutein supplementation in choroideremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean Bennett Research Topics

Disease

15	Retinal Degeneration 01/2022 - 08/2002
15	Blindness (Hysterical Blindness) 01/2021 - 06/2003
11	Retinal Diseases 10/2021 - 05/2003
11	Leber Congenital Amaurosis 09/2018 - 01/2004
10	Choroideremia 10/2022 - 03/2002
9	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2022 - 01/2011
3	Ganglion Cysts (Ganglion) 01/2021 - 12/2004
3	Optic Nerve Diseases (Optic Neuropathy) 01/2021 - 01/2014
3	Choroidal Neovascularization 04/2005 - 05/2003
2	Retinal Perforations 10/2022 - 05/2008
2	Cone-Rod Dystrophies 10/2018 - 12/2012
2	Agenesis of Cerebellar Vermis 09/2018 - 10/2013
2	Inflammation (Inflammations) 01/2018 - 08/2004
2	Ciliopathies 01/2018 - 06/2015
2	Disease Progression 09/2014 - 05/2013
1	Peroxisome biogenesis disorders 12/2021
1	Optic Nerve Injuries 01/2021
1	Atrophy 01/2019
1	Cone Dystrophy 01/2019
1	Photophobia (Light Sensitivity) 01/2019
1	Demyelinating Diseases (Demyelinating Disease) 01/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Multiple Sclerosis 01/2018
1	Opioid-Related Disorders (Opiate Addiction) 01/2018
1	Optic Neuritis (Retrobulbar Neuritis) 01/2018
1	Pain (Aches) 01/2018
1	Epilepsy (Aura) 08/2017
1	Infections 05/2014
1	Meckel syndrome type 1 10/2013
1	Senior Loken Syndrome 10/2013
1	type 2 Amaurosis congenita of Leber 01/2013
1	Macular Degeneration (Age-Related Maculopathy) 01/2011
1	Retinal Dystrophies 09/2010
1	Hydrocephalus (Hydrocephaly) 05/2007
1	Pneumonia (Pneumonitis) 05/2007
1	Hearing Loss (Hearing Impairment) 09/2006
1	Vascular System Injuries 09/2005
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2005
1	Macular Edema 04/2005
1	Vision Disorders (Hemeralopia) 04/2004
1	Stargardt Disease 03/2004
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2003
1	Hypoxia (Hypoxemia) 05/2003
1	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 11/2002
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2002

Drug/Important Bio-Agent (IBA)

35	Retinaldehyde (Retinal)IBA 01/2022 - 04/2003
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2004
3	Complementary DNA (cDNA)IBA 10/2022 - 04/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2005 - 05/2003
2	Sirtuin 1IBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 05/2013
2	RNA Precursors (Precursor, mRNA)IBA 01/2019 - 09/2018
2	Neuroprotective AgentsIBA 01/2018 - 11/2004
2	Rhodopsin (Visual Purple)IBA 01/2015 - 04/2011
2	Sirolimus (Rapamycin)FDA Link 12/2004 - 08/2002
2	pigment epithelium-derived factorIBA 11/2004 - 10/2002
2	Ceruloplasmin (Ferroxidase)IBA 08/2004 - 04/2003
1	Indicators and Reagents (Reagents)IBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	polyetheretherketoneIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2013
1	Retinal Pigments (Pigments, Visual)IBA 01/2013
1	Ammonium CompoundsIBA 07/2012
1	azobenzeneIBA 07/2012
1	Antisense OligonucleotidesIBA 03/2012
1	Viral AntigensIBA 11/2005
1	Oxygen (Dioxygen)IBA 09/2005
1	RetinoidsIBA 04/2005
1	N-Methylaspartate (NMDA)IBA 12/2004
1	Therapeutic UsesIBA 11/2004
1	PeripherinsIBA 11/2004
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 08/2004
1	Transcription Factors (Transcription Factor)IBA 08/2004
1	MetallothioneinIBA 08/2004
1	OsteopontinIBA 08/2004
1	AntioxidantsIBA 08/2004
1	ChitinasesIBA 08/2004
1	Chloride Channels (Chloride Channel)IBA 08/2004
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2004
1	SolutionsIBA 06/2003
1	Dermatan SulfateIBA 11/2002
1	EndostatinsIBA 10/2002
1	Tissue Inhibitor of Metalloproteinase-3IBA 10/2002
1	LuteinIBA 03/2002
1	Macular PigmentIBA 03/2002

Therapy/Procedure

24	Therapeutics 01/2022 - 08/2002
2	Injections 10/2022 - 01/2022
2	Intravitreal Injections 01/2021 - 12/2004
1	Pain Management 01/2018
1	Oral Surgery (Maxillofacial Surgery) 08/2017
1	Stem Cell Transplantation 10/2016
1	Cell Transplantation 10/2016
1	Lasers (Laser) 05/2003